Episode Details

On our latest Trade to Black podcast, hosts Shadd Dales and Anthony Varrell will discuss Tilray’s latest earnings. Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% yearly to $211 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 8.2% above analysts’ estimates. Its non-GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates. Here are some of the notable numbers Tilray (TLRY) Q4 CY2024 Highlights:

• Revenue: $211 million vs analyst estimates of $216.3 million (8.9% year-on-year growth, 2.5% miss)
• Adjusted EPS: $0 vs analyst estimates of -$0.01 ($0.01 beat)
• Adjusted EBITDA: $9.02 million vs analyst estimates of $12.3 million (4.3% margin, 26.7% miss)
• Management’s revenue guidance for the upcoming financial year 2025 is $975 million at the midpoint, beating analyst estimates by 8.2% and implying 17.6% growth (vs 19% in FY2024)
• Operating Margin: -20%, up from -21.6% in the same quarter last year
• Free Cash Flow was -$46.19 million compared to -$36.25 million in the same quarter last year
• Market Capitalization: $1.24 billion

On the company'ss, stated of Tilray BrandChairman and CEOIrwin D. Simon, earnings call, , "In our fiscal second quarter, Tilray achieved strong results while making significant progress on our strategic plan. We'll discuss a ce short term#cannabis #tilray #donaldtrump #marijuanastocks #cannabisindustry #trump #tilrayearnings #msos Want to watch more Trade To Black Videos? https://www.youtube.com/live/DHKjsOoW... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter! https://newsletter.thedalesreport.com... Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web: Facebook:   / thedalesreport   Twitter:

Listen Now